Heroin makes asthma difficult and sometimes nearly fatal.

[Heroin makes asthma difficult and sometimes nearly fatal]. Presse Med. 2015 Aug 31; Authors: Moreau L, Palot A, Tummino C, Alagha K, Bonnet D, Chanez P PMID: 26337357 [PubMed - as supplied by publisher]
Source: Presse Medicale - Category: Journals (General) Authors: Tags: Presse Med Source Type: research

Related Links:

Conclusion: Environmental exposure to DE is suggested to benefit patients with hypersensitivity through relieving inflammatory symptoms. In a sense of prevention, DE represents a potential material against development of asthma. PMID: 31803778 [PubMed]
Source: Iranian Journal of Arthropod-Borne Diseases - Category: Infectious Diseases Tags: J Arthropod Borne Dis Source Type: research
Funding Opportunity RFA-AI-19-068 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Immune Tolerance Network. The major goal of this Network is to develop tolerogenic approaches for the treatment and prevention of disease in three clinical areas: asthma and allergic diseases; autoimmune diseases; and immune-mediated consequences of allotransplantation. The scope of research to be carried out includes: 1) the design and conduct of clinical trials at all phases to evaluate the safety and efficacy of investigational products and approach...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Pulmonology, Asthma, Preventive Medicine, News, Source Type: news
We describe how the metabolic effects of O3, including effects within the lungs, are exacerbated in the setting of the metabolic derangements of obesity and we discuss epidemiological data indicating an association between ambient O3 exposure and diabetes. We conclude by describing the role of the gut microbiome in the regulation of metabolism and by discussing data indicating a link between the gut microbiome and pulmonary responses to O3.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Approximately 5–10% of asthmatic patients worldwide suffer from severe asthma. Experimental and clinical studies have demonstrated that IL-13 is an important cytokine in chronic airways inflammation. IL-13 is involved in Th2 inflammation and has been identified as a possible therapeutic target in the treatment of asthma. Two different human monoclonal antibodies (mAbs) anti-IL-13 (tralokinumab and lebrikizumab) block binding and signaling of IL-13 to its receptors, IL-13Rα1 and IL-13Rα2. Several randomized, double-blind, placebo-controlled multicenter studies have evaluated the safety and efficacy of tral...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Bioactive compounds from medicinal plants with anti-inflammatory and immunosuppressive effects have been emerging as important sources of drugs for the treatment of inflammatory disorders. Triptolide, a diterpene triepoxide, is a pharmacologically active compound isolated from Tripterygium wilfordii Hook F (TwHF) that is used as a remedy for inflammatory and autoimmune diseases. As the most promising bioactive compound obtained from TwHF, triptolide has attracted considerable interest recently, especially for its potent anti-inflammatory and immunosuppressive activities. Over the past few years, an increasing number of stu...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
(Natural News) Breastfeeding your baby can be a difficult task, but your hard work will surely pay off. Exclusively breastfeeding your child for the first three months can lower his or her risk of suffering from eczema later in life, according to a study presented in the American Academy of Allergy, Asthma &Immunology 2019...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Condition:   Asthma Interventions:   Drug: AZD8154 nebulizer suspension, 20 mg/mL;   Drug: Placebo Sponsors:   AstraZeneca;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Allergy;   Asthma;   Food Allergy;   Allergic Sensitisation;   Atopic Dermatitis Intervention:   Sponsors:   Pontificia Universidad Catolica de Chile;   University of Chile;   Comisión Nacional de Investigación Científica y Tecnológica Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Eosinophilic Asthma;   Chronic Sinusitis;   Eosinophilic Rhinitis Intervention:   Sponsor:   University Hospital, Lille Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asthma | General Medicine